Advanced search

Iain James Mackay occupies the position of Chief Financial Officer & Executive Director at GlaxoSmithKline Plc and Director & Finance Director at HSBC Holdings PLC (Hong Kong). He is also Court Member at the University of Aberdeen and Member of The Institute of Chartered Accountants of Scotland and on the board of 5 other companies.
He previously occupied the position of Executive Director & Group Finance Director at HSBC Holdings Plc Chief Financial Officer of The HongKong & Shanghai Banking Corp. Ltd. Chief Financial Officer at HSBC Asia Pacific Holdings (UK) Ltd. CFO & Senior Executive Vice President at HSBC Finance Corp. and Chief Financial Officer & Senior EVP at HSBC North America Holdings, Inc. (which are all subsidiaries of HSBC Holdings Plc), Finance Director-Europe, Africa & South East Asia at Dowell Schlumberger, Chief Financial Officer & Vice President for Global Life Sciences Solutions Manufacturing UK Ltd. and Chief Financial Officer & Vice President at GE Consumer Finance, Inc.
Mr. Mackay received a graduate degree from the University of Aberdeen.

Iain Ruaraidh Mackay is currently a Director at Red Sixty One Ltd.
He previously worked as a Non-Executive Director at Pufferfish Ltd.

Iain Mackay currently works at GB Snowsport Ltd., as Director.

Michelle M.
MacKay is currently the Chief Executive Officer & Director at Cushman & Wakefield Plc, the Chief Executive Officer at Cushman & Wakefield, Inc., the Chief Executive Officer at Cushman & Wakefield Sweden AB, and the Co-President, Chief Operating Officer & Director at Cushman & Wakefield Debenham Tie Leung Ltd.
Previously, she served as an Independent Director at WCI Communities, Inc. from 2009 to 2017, an Executive Director-Commercial Real Estate at UBS Warburg, Inc. from 1998 to 2001, an Assistant VP-Real Estate & Fixed Income at The Hartford Financial Services Group, Inc. from 1991 to 1996, a Vice President at Chase Bank USA, NA from 1996 to 1998, and an Executive VP-Investments & Head-Capital Markets at iStar, Inc. from 2003 to 2017.
She also served as an Independent Trustee at Americold Realty Trust, Inc. from 2018 to 2021.
Ms. MacKay holds an undergraduate degree from the University of Connecticut and an MBA from the University of Hartford.

Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Alick Mackay is currently the Director of Strategy & Corporate Development at Brooks MacDonald Group Plc since 2017.
Prior to this, he worked as the Chief Operating Officer at NatWest Group Plc.
Mr. Mackay has an undergraduate degree from the University of Aberdeen, a graduate degree from The Open University, and an MBA from Columbia Business School.

Dr. Iain D. Dukes is a Chief Executive Officer at Viriom, Inc., a President & Director at Kartos Therapeutics, Inc., an Independent Director at Ikena Oncology, Inc., a Venture Partner at OrbiMed Advisors Private Equity, a Chairman at Iovance Biotherapeutics, Inc., an Executive Chairman at Theseus Pharmaceuticals, Inc., a President at Telios Pharmaceuticals, Inc. and a President & Chief Executive Officer at Arrys Therapeutics, Inc. He is on the Board of Directors at Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Ikena Oncology, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. and ReViral Ltd. Dr. Dukes was previously employed as a Member-Supervisory Board by Themis Bioscience GmbH, a SVP & Head-Business Development by Merck Research Laboratories Massachusetts LLC, a VP-External Research & Development by Amgen, Inc., a President & Chief Executive Officer by Essentialis, Inc., a VP-Scientific and Technology Licensing by GlaxoSmithKline, Inc., a Head-Exploratory Development by Glaxo Wellcome, Inc., a Principal by Glaxo, Inc., and a Senior VP-Business Development & Licensing by Merck & Co., Inc. He also served on the board at KaNDy Therapeutics Ltd. He received his undergraduate degree from the University of Bath, an undergraduate degree from the University of Oxford, a graduate degree from the University of Leeds and a doctorate degree from the University of Oxford.

Iain G. T. Ferguson is a businessperson who has been the head of 11 different companies and presently is Non-Executive Chairman at Genus Plc, Non-Executive Chairman at Crest Nicholson Holdings Plc, Non-Executive Chairman of Crest Nicholson Plc (a subsidiary of Crest Nicholson Holdings Plc) and Chairman at Hallmarq Veterinary Imaging Ltd. Mr. Ferguson is also Chancellor at Cranfield University and on the board of 5 other companies. In his past career Iain G. T. Ferguson occupied the position of Non-Executive Chairman at Stobart Group Ltd., Chief Executive Officer at Tate & Lyle Plc, Senior Vice President-Corporate Development at Unilever Plc, Non-Executive Chairman for Berendsen Ltd., Chief Executive Officer for Birds Eye Ltd., Member of PricewaterhouseCoopers LLP (United Kingdom), Member-Strategy Group at United Kingdom Department for Business, Innovation & Skills, Chairman of Wilton Park, President of The Institute of Grocery Distribution and President at The Food & Drink Federation. Mr. Ferguson received an undergraduate degree from the University of St. Andrews.

Iain Rob Rayner occupies the position of Joint Chief Operating Officer at St. James's Place Plc. Mr. Rayner is also on the board of St. James’s Place Acquisition Services Ltd. and St. James's Place DFM Holdings Ltd.

Iain Wetherall occupies the position of Chief Investment Officer of Wizz Air Holdings Plc.

Iain Michael Brown holds the position of Senior VP, Chief Financial & Accounting Officer at Alkermes Plc. In his past career Mr. Brown occupied the position of Vice President-Finance for Alkermes, Inc. and Vice President-Finance at EMD Serono, Inc. He received an undergraduate degree from the University of Bradford.

Presently, Iain Boyd holds the position of Vice President-Operations Development at Snap-On, Inc. He previously occupied the position of Vice President-Human Resources of Snap-on Tools Co. LLC.

Iain Charles Andrew Cornish is a businessperson who has been at the head of 6 different companies. Presently, he is Chairman at Leeds Building Society. Mr. Cornish is also Treasurer & Trustee at Macmillan Cancer Support and on the board of 5 other companies. Mr. Cornish previously was Chairman for St. James's Place Plc, Chairman of Shawbrook Group Plc and Chairman of Shawbrook Bank Ltd. (a subsidiary of Shawbrook Group Plc), Chief Executive Officer of Yorkshire Building Society and Chairman at Building Societies Association. He received an undergraduate degree from The University of Southampton.

Presently, Iain Blacklaw holds the position of Chief Operating Officer of National Bank of Bahrain. In the past he occupied the position of Chief Operating Officer for Al Rajhi Bank. He received an undergraduate degree from the University of Aberdeen.

Currently, Iain George Williamson is Chief Executive Officer & Executive Director at Old Mutual Ltd. and Chief Executive Officer at Old Mutual Life Assurance Co. (South Africa) Ltd. (a subsidiary of Old Mutual Ltd.) and Chief Executive Officer of Old Mutual Life Assurance Co. Ltd. He is also on the board of Nedbank Group Ltd., Nedbank Ltd. and UAP Old Mutual Group Ltd. Mr. Williamson previously held the position of Finance Director of Old Mutual Emerging Markets Ltd.

Iain C. Conn is on the board of BT Group Plc and Oxford Flow Ltd. and Member of European Round Table of Industrialists. In the past Mr. Conn was Chief Executive Officer & Executive Director at Centrica Plc, Executive Director & CEO-Marketing & Refining at BP Plc and Chief Executive Officer for BP Petrochemicals Ltd. (a subsidiary of BP Plc) and Council Member at Imperial College London. He received an undergraduate degree from Imperial College London.

Iain - has worked as the Chairman at Mirion Technologies (IST France) SAS since 2011.

Harvey B.
Mackay is currently the Chairman of MackayMitchell Envelope Co. and a Director of Minnesota Orchestral Association.

Mark B.
Mackay worked as Vice President-Engineering & Construction at TransAlta Corp.
from 2012 to 2020.
Prior to that, he worked as Vice President at TransCanada PipeLines Ltd.
Mr. Mackay completed his undergraduate degree at the University of British Columbia.

Danny Colin Keith MacKay is currently the Chief Executive Officer at Tactical Software Systems Pty Ltd., Chairman at Quadrem Africa Pty Ltd., Director at Black Information Technology Empowerment Co. Ltd., and Director at Ariba South Africa.
He previously worked as a Non-Executive Director at EOH Holdings Ltd.
from 2014 to 2017.

Jeffrey K.
MacKay worked as a Treasurer & Vice President at The Dayton Power & Light Co. and DPL, Inc.

Catherine Mackay currently works at Amplify Education, Inc., as President & Chief Operating Officer from 2018.

Derek C.
Mackay worked as a Vice President-Finance at ONEX Corp.
and as a Senior Associate at PricewaterhouseCoopers LLP (Canada).
He completed his undergraduate degree at Wilfrid Laurier University.

Jason M.
Mackay is currently a Director at Adderstone (201) Ltd.
Prior to this, he was a Non-Executive Director at Audioboom Group Plc from 2014 to 2017.
He also held positions as Head of UK Equities at GLG Partners LP and Co-Head of UK Equities at Man Group Investments Ltd.
from 2004 to 2010.

Mr. Greg Mackay is Founding Director at Mundane Asset Management Ltd.
He is the business manager for Mundane.
Mr. Mackay started his career in Johannesburg in 1980 and became a member of the JSE in 1984.
From 1987 he has worked in London as a director of stockbroking divisions of leading investment banks.
Mr. Mackay was a director of ING Barings in London from 1995 to 2001.

Margaret MacKay is currently a Non-Executive Director at Scottish Building Society since 2017.
Prior to this, she worked as a Managing Director at Clydeport Ltd.

Mr. Steve Mackay is Chief Financial Officer at Pumpkin Patch Ltd.

Carla Mackay worked as the Chief Financial Officer at Invictus Energy Ltd.
from 2013 to 2014.
She obtained an undergraduate degree from the University of Johannesburg.

Mr. Tom Mackay is a Senior Independent Non-Executive Director at Aminex Plc.
He is on the Board of Directors at Aminex Plc and Upstream Solutions Ltd.
Mr. Mackay was previously employed as a Manager-Existing Ventures by Clyde Petroleum Plc, a Partner by Gemini Oil & Gas Advisors LLP, a Chief Executive Officer & Director by Oilquest Ltd., and a General Manager by Stratic Energy Corp.
He also served on the board at Oil Quest Holdings Ltd.
He received his undergraduate degree from the University of Durham.

Douglas Duffy MacKay held the following former jobs: Senior VP-Scientific & Regulatory Affairs at CV Sciences, Inc. from 2019 to 2021, Senior VP-Scientific & Regulatory Affairs at Council for Responsible Nutrition from 2008 to 2018, and Vice President-Clinical Research at Nordic Pharma, Inc. AS from 2004 to 2008.
He received his undergraduate degree from the University of California, Santa Cruz in 1994 and his doctorate degree from National College of Natural Medicine in 2001.

James M.
Mackay is the founder of Aristea Therapeutics, Inc. (founded in 2018) where he holds the title of President & Chief Executive Officer.
He is currently the Chairman at CONNECT since 2014, Director at BIOCOM, Director at MatriSys Bioscience, Inc. (since 2020), Director at Arthrosi Therapeutics, Inc. (since 2021), and Independent Director at Privo Technologies, Inc. Dr. Mackay previously served as President & Chief Executive Officer at Ardea Biosciences, Inc. (2013-2018), Director & Trustee at San Diego Regional Economic Development Corp.
(2017-2018), and Vice President-Global Product at AstraZeneca PLC (2008-2016).
He obtained undergraduate and doctorate degrees from the University of Aberdeen.

Giles Patrick Cyril Mackay is currently a Director at ResiManagement Ltd., PXS 3 Ltd., Heylo Housing Secured Bond Plc, Heylo Housing Group Ltd., GPCM Holdco Ltd., GPCM Finco Ltd., Statuslist Ltd., Worthearly Ltd., Assettrust Ltd., HH No.
3 Ltd., HH No.
2 Ltd., and HH No.
5 Ltd.
He was formerly a Director at Hometrack Co. UK Ltd.

Billy Mackay is the founder of Boon Co., Inc. He is currently working as the Managing Director-Advised at AJ Bell Plc.

Thomas Mackay is currently the Chief Financial Officer, Director & SVP at Virgin Atlantic Airways Ltd.
He is also a Director at Virglease Ltd., Virgin Travel Group Ltd., Virglease (3) Ltd., Junopart Ltd., VA Cargo Ltd., Virgin Atlantic Two Ltd., and Virgin Atlantic International Ltd.
Previously, he served as the Chief Financial Officer & Director at Virgin Atlantic Ltd.

Malcolm MacKay currently works at Sheltering Arms Children & Family Services, Inc., as Director.

Anthony Mackay is the founder of Kryptos-X Pte.
Ltd.
He currently serves as the Chairman-Emeritus at CXGH LLC.
Previously, he worked as a Non-Executive Director at Fatfish Group Ltd.
from 2018 to 2019.

Colin Mackay currently works at Elian Fiduciary Services (Cayman) Ltd., as Chief Executive Officer from 2011 and Maclay Murray & Spens LLP.
Mr. Mackay also formerly worked at EMR Capital Pty Ltd., as Board Director and Ogier Group LP, as Partner.
Mr. Mackay received his graduate degree in 1991 from the University of Glasgow.

Mark R.
MacKay is currently a Director at Attune Consulting USA LLC since 2013.
Prior to this, he held various Principal and Vice President positions at companies such as The Black & Decker Corp., Everlast Worldwide, Inc., The Basketball Marketing Co., Inc., The Rockport Co. LLC, L'Oréal USA, Inc., Philip Morris USA, Inc., Under Armour, Inc., Icpw Liquidation Corp., and Reebok USA Ltd.

Andrew Ryan MacKay is currently working as a Vice President & Global Credit Strategist at Loomis, Sayles & Co. LP.
He started this job in 2018.
In terms of education, Mr. MacKay completed his undergraduate degree at the University of New Hampshire.
He also obtained an MBA from the Wallace E Carroll School of Management in 2002.

Matthew B.
MacKay is the founder of Surge LLC, where he currently holds the title of Chief Executive Officer since 2007.
Mr. MacKay is also the founder of Remedy Informatics, Inc...
Mr. MacKay's former job positions include Software Engineer at PACCAR, Inc. and Vice President at TenFold Corp.
Mr. MacKay obtained his undergraduate degree from Brigham Young University.

Gavin Mackay worked as Head of Investor Relations and Business Development at Aquarius Platinum Ltd.
in 2011 and as Head of Business Development and Investor Relations at Ferrexpo Plc.
Mr. Mackay completed his undergraduate degree at the University of Cape Town and his graduate degree at the University of the Witwatersrand.